tirzepatide monitoring Does Lower Blood Pressure? At a glance factsheet: Tirzepatide
Description
Repeated injections in the same spot cause lipodystrophy, a condition where the fat tissue under the skin hardens, thins, or develops lumps
Panel B, mean (95% confidence interval) change from baseline over time in diastolic blood pressure from start of intensive-lifestyle intervention lead-in period (week -12) to 72 weeks using observed means
Semaglutide escalates in uneven steps (0.25, 0.5, 1.0, 1.7, 2.4 mg) while tirzepatide increases in uniform 2.5 mg increments (2.5, 5.0, 7.5, 10.0, 12.5, 15.0 mg)
These are usually tolerable and improve as the body adapts
